Increased Rates of Allogeneic Hematopoietic Stem Cell Transplantation and Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients with Broader Health Insurance Coverage

Jeremy Chang; Sherry Zhang; Mojtaba Akhtari

doi:10.1016/J.BBMT.2019.12.628

Increased Rates of Allogeneic Hematopoietic Stem Cell Transplantation and Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients with Broader Health Insurance Coverage

Jeremy Chang, Sherry Zhang, Mojtaba Akhtari

Medicine

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Biology of Blood and Marrow Transplantation
Volume	26
DOIs	https://doi.org/10.1016/J.BBMT.2019.12.628
State	Published - Mar 1 2020

Disciplines

Internal Medicine
Medicine and Health Sciences

Access to Document

10.1016/J.BBMT.2019.12.628License: Unspecified

OpenUrl availability

Full text

Cite this

Increased Rates of Allogeneic Hematopoietic Stem Cell Transplantation and Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients with Broader Health Insurance Coverage. / Chang, Jeremy; Zhang, Sherry; Akhtari, Mojtaba.
In: Biology of Blood and Marrow Transplantation, Vol. 26, 01.03.2020.

Research output: Contribution to journal › Article › peer-review

@article{ecf213fc7d774590aed7d9da9ef015a3,

title = "Increased Rates of Allogeneic Hematopoietic Stem Cell Transplantation and Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients with Broader Health Insurance Coverage",

author = "Jeremy Chang and Sherry Zhang and Mojtaba Akhtari",

note = "The Philadelphia chromosome is associated with a poor prognosis in patients with acute lymphoblastic leukemia (ALL). While modern day therapies including allogeneic hematopoietic stem cell transplantation (HSCT) have led to significant improvements in overall survival (OS) for this population, these treatments have variable accessibility in patients with limited to no health insurance.",

year = "2020",

month = mar,

day = "1",

doi = "10.1016/J.BBMT.2019.12.628",

language = "American English",

volume = "26",

journal = "Biology of Blood and Marrow Transplantation",

}

TY - JOUR

T1 - Increased Rates of Allogeneic Hematopoietic Stem Cell Transplantation and Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients with Broader Health Insurance Coverage

AU - Chang, Jeremy

AU - Zhang, Sherry

AU - Akhtari, Mojtaba

N1 - The Philadelphia chromosome is associated with a poor prognosis in patients with acute lymphoblastic leukemia (ALL). While modern day therapies including allogeneic hematopoietic stem cell transplantation (HSCT) have led to significant improvements in overall survival (OS) for this population, these treatments have variable accessibility in patients with limited to no health insurance.

PY - 2020/3/1

Y1 - 2020/3/1

UR - https://www.sciencedirect.com/science/article/pii/S1083879119315575

U2 - 10.1016/J.BBMT.2019.12.628

DO - 10.1016/J.BBMT.2019.12.628

M3 - Article

VL - 26

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

ER -

Increased Rates of Allogeneic Hematopoietic Stem Cell Transplantation and Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients with Broader Health Insurance Coverage

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this